Tag: <span>aspirin</span>

Home / aspirin
Colorectal cancer: Aspirin found to activate protective genes
Post

Colorectal cancer: Aspirin found to activate protective genes

by Ludwig Maximilian University of Munich Salicylate suppresses viability and proliferation of CRC cells independent of p53. A Cell viability of HCT116 cells was determined by MTT assay after treatment with indicated concentrations of salicylate for 48 h. IC50 was determined using GraphPad Prism based on changes in viability. B Cell viability of non-transformed CCD-18-Co and HCEC-1CT...

For some cardiac patients with stents, long-term aspirin treatments might be on the way out
Post

For some cardiac patients with stents, long-term aspirin treatments might be on the way out

By Giri Viswanathan, CNN New research re-evaluates aspirin’s role in long-term treatment plans for patients with stents.Grace Cary/Moment RF/Getty ImagesCNN — For some high-risk cardiovascular patients with stents, the often-recommended practice of prolonged taking of aspirin might be ineffective, and in some cases, even harmful, a new study found. The report, published in the scientific journal...

Post

Aspirin Use Tied to Lower Risk for Early Colorectal Cancer

Walter Alexander June 01, 2023 CHICAGO – The regular use of aspirin or other nonsteroidal anti-inflammatory drugs was found to be associated with a lower risk of early-onset conventional and advanced adenomas. The authors say that aspirin could prove to be an effective strategy in preventing early-onset colorectal cancer cases. “What we have here is a 15% reduction for...

Aspirin reduces ovarian cancer risk regardless of genetic predisposition
Post

Aspirin reduces ovarian cancer risk regardless of genetic predisposition

By Paul McClure February 26, 2023 A new study suggests that genetic susceptibility to ovarian cancer does not affect the protective effect of aspirin in reducing ovarian cancer risk Depositphotos Ovarian cancer is a highly fatal type of cancer that can be caused by several genetic factors. A recent study examined whether the protection provided...

Post

Meta-Analysis Throws More Shade Aspirin’s Way

Richard Mark Kirkner February 15, 2023 A new meta-analysis has added evidence questioning the utility and efficacy of prophylactic low-dose aspirin for preventing cardiovascular events in people who don’t have atherosclerotic cardiovascular disease (ASCVD), whether or not they’re also taking statins, and finds that at every level of ASCVD risk the aspirin carries a risk of major bleeding that exceeds its...

Aspirin as effective as standard blood thinner to prevent life-threatening blood clots and death after fracture surgery
Post

Aspirin as effective as standard blood thinner to prevent life-threatening blood clots and death after fracture surgery

by University of Maryland School of Medicine Credit: Unsplash/CC0 Public Domain Patients who have surgery to repair bone fractures typically receive a type of injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots, but a new clinical trial found that over-the-counter aspirin is just as effective. The findings, presented today at the Orthopedic Trauma Association (OTA)...

Aspirin as effective as standard blood thinner to prevent life-threatening blood clots and death after fracture surgery
Post

Aspirin as effective as standard blood thinner to prevent life-threatening blood clots and death after fracture surgery

by University of Maryland School of Medicine Credit: Unsplash/CC0 Public Domain Patients who have surgery to repair bone fractures typically receive a type of injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots, but a new clinical trial found that over-the-counter aspirin is just as effective. The findings, presented today at the Orthopedic Trauma...

Study finds daily aspirin does not prevent recurrence of breast cancer
Post

Study finds daily aspirin does not prevent recurrence of breast cancer

(HealthDay)—Regular aspirin use does not improve invasive disease-free survival (iDFS) among high-risk breast cancer patients with human epidermal growth factor receptor 2 (HER2)-negative disease, according to a study presented Feb. 15 as part of the American Society for Clinical Oncology Plenary Series. Wendy Y. Chen, M.D., M.P.H., from the Dana Farber Cancer Institute in Boston,...

  • 1
  • 2
  • 4